Huperzine A for Alzheimer's disease: a systematic review and meta-analysis of randomized clinical trials.
<h4>Background</h4>Huperzine A is a Chinese herb extract used for Alzheimer's disease. We conducted this review to evaluate the beneficial and harmful effect of Huperzine A for treatment of Alzheimer's disease.<h4>Methods</h4>We searched for randomized clinical tria...
Enregistré dans:
Auteurs principaux: | Guoyan Yang, Yuyi Wang, Jinzhou Tian, Jian-Ping Liu |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2013
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/01426edd48dc4a959458e46f8ddbc23c |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Huperzine A and Its Neuroprotective Molecular Signaling in Alzheimer’s Disease
par: María Jesús Friedli, et autres
Publié: (2021) -
Physical activity can improve cognition in patients with Alzheimer’s disease: a systematic review and meta-analysis of randomized controlled trials
par: Du Z, et autres
Publié: (2018) -
Administration of dietary antioxidants for patients with inflammatory bowel disease: A systematic review and meta-analysis of randomized controlled clinical trials
par: Hossein Shahinfar, et autres
Publié: (2021) -
Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer’s disease
par: Meng QQ, et autres
Publié: (2018) -
Somatostatin analog therapy effectiveness on the progression of polycystic kidney and liver disease: A systematic review and meta-analysis of randomized clinical trials.
par: Tatsuya Suwabe, et autres
Publié: (2021)